R1 RCM Inc. (RCM): Price and Financial Metrics
GET POWR RATINGS... FREE!
RCM POWR Grades
- Momentum is the dimension where RCM ranks best; there it ranks ahead of 48.83% of US stocks.
- The strongest trend for RCM is in Stability, which has been heading down over the past 179 days.
- RCM ranks lowest in Value; there it ranks in the 5th percentile.
RCM Stock Summary
- With a year-over-year growth in debt of 126.25%, R1 RCM INC's debt growth rate surpasses 89.97% of about US stocks.
- Over the past twelve months, RCM has reported earnings growth of -97.94%, putting it ahead of only 14.77% of US stocks in our set.
- In terms of volatility of its share price, RCM is more volatile than 87.26% of stocks we're observing.
- Stocks that are quantitatively similar to RCM, based on their financial statements, market capitalization, and price volatility, are PSTL, EVA, IIPR, HIVE, and PDS.
- RCM's SEC filings can be seen here. And to visit R1 RCM INC's official web site, go to www.r1rcm.com.
RCM Valuation Summary
- RCM's price/sales ratio is 3.2; this is 28% higher than that of the median Technology stock.
- Over the past 112 months, RCM's EV/EBIT ratio has gone up 2537.4.
Below are key valuation metrics over time for RCM.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RCM | 2023-03-21 | 3.2 | 2.1 | -101.3 | 2540.7 |
| RCM | 2023-03-20 | 3.1 | 2.1 | -98.7 | 2492.1 |
| RCM | 2023-03-17 | 3.0 | 2.0 | -95.3 | 2426.8 |
| RCM | 2023-03-16 | 3.1 | 2.1 | -98.5 | 2486.5 |
| RCM | 2023-03-15 | 3.1 | 2.1 | -98.4 | 2485.1 |
| RCM | 2023-03-14 | 3.1 | 2.1 | -98.7 | 2492.1 |
RCM Growth Metrics
- Its 2 year price growth rate is now at 87.54%.
- Its year over year revenue growth rate is now at 17.39%.
- The 2 year revenue growth rate now stands at 23.32%.
The table below shows RCM's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 1,806.4 | -9.9 | -57.6 |
| 2022-09-30 | 1,672.5 | 6.5 | 15.5 |
| 2022-06-30 | 1,556.2 | 70.8 | 62 |
| 2022-03-31 | 1,517.7 | 249.7 | 100.8 |
| 2021-12-31 | 1,474.6 | 264.8 | 97.2 |
| 2021-09-30 | 1,404.1 | 230.1 | 139.8 |
RCM's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- RCM has a Quality Grade of C, ranking ahead of 32.75% of graded US stocks.
- RCM's asset turnover comes in at 1.132 -- ranking 100th of 561 Business Services stocks.
- ASGN, SNAP, and WIX are the stocks whose asset turnover ratios are most correlated with RCM.
The table below shows RCM's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.132 | 0.194 | 0.159 |
| 2021-03-31 | 1.108 | 0.200 | 0.156 |
| 2020-12-31 | 1.135 | 0.196 | 0.160 |
| 2020-09-30 | 1.192 | 0.188 | 0.106 |
| 2020-06-30 | 1.278 | 0.195 | 0.134 |
| 2020-03-31 | 1.335 | 0.184 | 0.096 |
RCM Price Target
For more insight on analysts targets of RCM, see our RCM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $32.18 | Average Broker Recommendation | 1.35 (Strong Buy) |
RCM Stock Price Chart Interactive Chart >
RCM Price/Volume Stats
| Current price | $14.30 | 52-week high | $27.86 |
| Prev. close | $13.75 | 52-week low | $6.71 |
| Day low | $13.60 | Volume | 4,647,000 |
| Day high | $14.33 | Avg. volume | 2,695,251 |
| 50-day MA | $13.83 | Dividend yield | N/A |
| 200-day MA | $16.82 | Market Cap | 5.96B |
R1 RCM Inc. (RCM) Company Bio
R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is based in Chicago, Illinois.
Latest RCM News From Around the Web
Below are the latest news stories about R1 RCM INC that investors may wish to consider to help them evaluate RCM as an investment opportunity.
Those who invested in R1 RCM (NASDAQ:RCM) five years ago are up 84%Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying... |
R1 RCM Issues 2022 Environmental, Social, and Governance ReportReport details company’s continued commitment to corporate responsibility and sustainability on behalf of its customers and their patients, employees, communities, and shareholdersMURRAY, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today released its 2022 Environmental, Social, and Governance (ESG) report, highlighting its commitment to |
R1 RCM (RCM) Faced Multiple Challenges in Q4ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed the Russell 2000 Index in the fourth quarter. The strategy gained in eight of the eleven sectors it was invested in the quarter on an absolute basis. […] |
R1 RCM to Present at Upcoming Investor ConferencesMURRAY, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences: The 43rd Annual Cowen Health Care Conference on Tuesday, March 7 at 11:10am ETThe Barclays Global Healthcare Conference on Thursday, March 16 at 8:00am ET A live audio webcast of the presentation will be avai |
R1 RCM Full Year 2022 Earnings: EPS Misses ExpectationsR1 RCM ( NASDAQ:RCM ) Full Year 2022 Results Key Financial Results Revenue: US$1.81b (up 23% from FY 2021). Net loss... |
RCM Price Returns
| 1-mo | -0.28% |
| 3-mo | 31.19% |
| 6-mo | -22.32% |
| 1-year | -43.70% |
| 3-year | 58.01% |
| 5-year | 89.40% |
| YTD | 30.59% |
| 2022 | -57.04% |
| 2021 | 6.12% |
| 2020 | 85.05% |
| 2019 | 63.27% |
| 2018 | 80.27% |
Continue Researching RCM
Want to see what other sources are saying about R1 Rcm Inc's financials and stock price? Try the links below:R1 Rcm Inc (RCM) Stock Price | Nasdaq
R1 Rcm Inc (RCM) Stock Quote, History and News - Yahoo Finance
R1 Rcm Inc (RCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...